A study in monkeys finds that treatment with the protein interferon protects against simian immunodeficiency virus, but that prolonged interferon administration exacerbates the chronic stage of the infection. See Letter p.601
References
Longo, D. L. et al. Ann. NY Acad. Sci. 437, 421–430 (1984).
Sandler, G. N. et al. Nature 511, 601–605 (2014).
Schoggins, J. W. Curr. Opin. Virol. 6C, 40–46 (2014).
Harris, R. S., Hultquist, J. F. & Evans, D. T. J. Biol. Chem. 287, 40875–40883 (2012).
Asmuth, D. M. et al. J. Infect. Dis. 201, 1686–1696 (2010).
Torriani, F. J. et al. N. Engl. J. Med. 351, 438–450 (2004).
Borden, E. C. & Murphy, F. A. J. Immunol. 106, 134–142 (1971).
Rotger, M. et al. PLoS Pathog. 6, e1000781 (2010).
Bosinger, S. E. et al. J. Clin. Invest. 119, 3556–3572 (2009).
Fenton-May, A. E. et al. Retrovirology 10, 146 (2013).
Ivashkiv, L. B. & Donlin, L. T. Nature Rev. Immunol. 14, 36–49 (2014).
Medzhitov, R., Schneider, D. S. & Soares, M. P. Science 335, 936–941 (2012).
Rotger, M. et al. J. Clin. Invest. 121, 2391–2400 (2011).
Rausell, A., McLaren, P. J. & Telenti, A. F1000Prime Rep. 5, 29 (2013).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Telenti, A. The mixed blessing of interferon. Nature 511, 537–538 (2014). https://doi.org/10.1038/nature13517
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature13517
- Springer Nature Limited
This article is cited by
-
Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses
Retrovirology (2015)
-
Reducing IRF-1 to Levels Observed in HESN Subjects Limits HIV Replication, But Not the Extent of Host Immune Activation
Molecular Therapy - Nucleic Acids (2015)